Department of Cardiothoracic Surgery, University Medical Center, Regensburg, Germany.
Eur J Cardiothorac Surg. 2011 Apr;39(4):459-64. doi: 10.1016/j.ejcts.2010.08.006. Epub 2010 Sep 18.
Coronary artery bypass grafting (CABG) is the gold standard for the surgical therapy of multivessel coronary artery disease. To reduce the side effects, associated with standard extracorporeal circulation (ECC), a concept of minimal extracorporeal circulation (MECC) was devised in our center. We report on our 10-year experience with the MECC for coronary revascularization.
From January 1998 to August 2009, 2243 patients underwent CABG with MECC in our center. In a retrospective observational study, we analyzed indication, preoperative patient co-morbidity, postoperative clinical course, and perioperative outcome of all patients operated on with MECC. Furthermore, the risk factors for mortality in the MECC group were assessed.
Patients showed a mean logistic European System for Cardiac Operative Risk Evaluation (EuroSCORE) of 4.5±0.1%. The mean age of the patients was 66.8±9.1 years. The overall 30-day mortality after CABG with MECC was 2.3%, ranging from 1.1% for elective to 13.0% for emergent patients and was significantly better than standard ECC. Only 15.3% (n=344) of patients with MECC required intra-operative blood transfusion. Postoperative catecholamine support, red blood cell transfusion, need for hemodialysis, release of creatinine kinase, incidence of stroke, and postoperative delirium were low after MECC revascularization. Ejection fraction below 30% (odds ratio (OR): 5.1), emergent operation (OR: 9.4), and high-dose catecholamine therapy (OR: 2.6) were associated predictors for mortality.
MECC until now is an established concept and has become an alternative for ECC in routine CABG in our center. The use of the MECC system is associated with low mortality and conversion rate. Excellent survival rates and low transfusion requirements in the perioperative course were achieved.
冠状动脉旁路移植术(CABG)是多支冠状动脉疾病外科治疗的金标准。为了减少与标准体外循环(ECC)相关的副作用,我们中心设计了一种微创体外循环(MECC)的概念。我们报告了我们中心 10 年来使用 MECC 进行冠状动脉血运重建的经验。
从 1998 年 1 月至 2009 年 8 月,我们中心共有 2243 例患者接受 MECC 下 CABG。在一项回顾性观察研究中,我们分析了所有接受 MECC 手术的患者的适应证、术前患者合并症、术后临床过程和围手术期结果。此外,还评估了 MECC 组患者死亡的危险因素。
患者的欧洲心脏手术风险评估系统(EuroSCORE)平均为 4.5±0.1%。患者的平均年龄为 66.8±9.1 岁。MECC 下 CABG 的 30 天死亡率为 2.3%,择期手术为 1.1%,急诊手术为 13.0%,明显优于标准 ECC。只有 15.3%(n=344)的 MECC 患者需要术中输血。MECC 血运重建后,儿茶酚胺支持、红细胞输血、需要血液透析、肌酸激酶释放、中风发生率和术后谵妄发生率较低。射血分数低于 30%(比值比(OR):5.1)、急诊手术(OR:9.4)和高剂量儿茶酚胺治疗(OR:2.6)是死亡的相关预测因素。
到目前为止,MECC 已经成为一种既定的概念,并已成为我们中心常规 CABG 中 ECC 的替代方案。使用 MECC 系统与低死亡率和转换率相关。在围手术期实现了优异的存活率和低输血需求。